Cite

HARVARD Citation

    Osum, S. et al. (2021). Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo. Neuro-oncology advances. 3 (1), p. . [Online]. 
  
Back to record